Lilly claims Premier Weight Loss is selling altered versions of Lilly's weight loss drugs Zepbound and Mounjaro. In the lawsuit, Lilly alleges Premier Weight Loss is falsely marketing Lilly's products ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...

Since 2023, Lilly has taken action against dozens of pharmacies, weight-loss centers and health spas over the drugs Mounjaro and Zepbound accounted for more than one-third of Lilly’s record $45 ...

Tirzepatide is the ingredient behind Lilly's major obesity and diabetes franchise Zepbound and Mounjaro and works as a long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and ...

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors.